Use of Asthma Medication During Gestation and Risk of Specific Congenital Anomalies

Cohen J.M. Bateman B.T. Huybrechts K.F. et al.

Poorly controlled asthma during pregnancy remains common in the United States.

J Allergy Clin Immunol In Pract. 7: 2672-2680. e2610Sawicki E. Stewart K. Wong S. et al.

Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital.

Aust N Z J Obstet Gynaecol. 51: 333-338Rejnö G. Lundholm C. Gong T. et al.

Asthma during pregnancy in a population-based study-pregnancy complications and adverse perinatal outcomes.

PLoS One. 9Kwon H.L. Belanger K. Bracken M.B.

Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys.

Ann Epidemiol. 13: 317-324Hansen C. Joski P. Freiman H. et al.

Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.

Matern child Health J. 17: 1611-1621Wang G. Murphy V.E. Namazy J. et al.

The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis.

J Maternal-Fetal Neonatal Med. 27: 934-942Kim S. Kim J. Park S.Y. et al.

Effect of pregnancy in asthma on health care use and perinatal outcomes.

J Allergy Clin Immunol. 136: 1215-1223. e1216Murphy V. Namazy J. Powell H. et al.

A meta-analysis of adverse perinatal outcomes in women with asthma.

BJOG: An Int J Obstet Gynaecol. 118: 1314-1323

Global Strategy for Asthma Management and Prevention.

Global Initiative for Asthma.

ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy.

Obstet Gynecol. 111: 457-464Al Ghobain M.O. AlNemer M.

Assessment of knowledge and education relating to asthma during pregnancy among women of childbearing age.

Asthma Res Pract. 4: 1-5Powell H. McCaffery K. Murphy V.E. et al.

Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.

J Asthma. 48: 1032-1040

Asthma education and outcomes for women of childbearing age.

Case manager. 14: 58-61Lim A.S. Stewart K. Abramson M.J. et al.

Management of asthma in pregnant women by general practitioners: a cross sectional survey.

BMC Fam Pract. 12: 1-7

Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy.

Reprod Toxicol. 32: 189-197Yland J.J. Bateman B. Huybrechts K.F. et al.

Fetal Outcomes Among Women with Asthma during Pregnancy: Evidence from a Large Healthcare Database in the United States.

J Allergy Clin Immunol. 143: AB422Garne E. Hansen A.V. Morris J. et al.

Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study.

J Allergy Clin Immunol. 136: 1496-1502. e1497

Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.

J Allergy Clin Immunol. 121: 1379-1384. e1371Crane J.P. LeFevre M.L. Winborn R.C. et al.

A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses.

Am J Obstet Gynecol. 171: 392-399

Genetic and epigenetic insights into fetal alcohol spectrum disorders.

Genome Med. 2: 1-8Torfs C.P. Christianson R.E. Iovannisci D.M. et al.

Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis.

Birth Defects Res A: Clin Mol Teratology. 76: 723-730Mossey P.A. Little J. Munger R.G. et al.

Cleft lip and palate.

Lancet. 374: 1773-1785Hyoun S.C. Običan S.G. Scialli A.R.

Teratogen update: methotrexate.

Birth Defects Res Part A: Clin Mol Teratology. 94: 187-207Diav-Citrin O. Shechtman S. Tahover E. et al.

Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.

Am J Psychiatry. 171: 785-794Veroniki A.A. Cogo E. Rios P. et al.

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.

BMC Med. 15: 1-20Shanks N. Greek R. Greek J.

Are animal models predictive for humans?.

Philos Ethics humanities Med. 4: 1-20

Drugs as teratogens.

CRC press, ClevelandRobijn A.L. Barker D. Gibson P.G. et al.

Factors Associated with Nonadherence to Inhaled Corticosteroids for Asthma During Pregnancy.

The J Allergy Clin Immunol In Pract. 9: 1242-1252. e1241Schatz M. Dombrowski M.P. Wise R. et al.

The relationship of asthma medication use to perinatal outcomes.

J Allergy Clin Immunol. 113: 1040-1045Murphy V.E. Clifton V.L. Gibson P.G.

Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes.

Thorax. 61: 169-176Abdullah K. Zhu J. Gershon A. et al.

Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study.

Eur Respir J. 55Breton M.-C. Martel M.-J. Vilain A. et al.

Inhaled corticosteroids during pregnancy: a review of methodologic issues.

Respir Med. 102: 862-875Schatz M. Zeiger R.S. Harden K. et al.

The safety of asthma and allergy medications during pregnancy.

J Allergy Clin Immunol. 100: 301-306Silverman M. Sheffer A. Diaz P.V. et al.

Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide.

Ann Allergy Asthma Immunol. 95: 566-570Bakhireva L.N. Jones K.L. Schatz M. et al.

Asthma medication use in pregnancy and fetal growth.

J Allergy Clin Immunol. 116: 503-509Perlow J.H. Montgomery D. Morgan M.A. et al.

Severity of asthma and perinatal outcome.

Am J Obstet Gynecol. 167: 963-967Alexander S. Dodds L. Armson B.A.

Perinatal outcomes in women with asthma during pregnancy.

Obstet Gynecol. 92: 435-440Dombrowski M.P. Schatz M. Wise R. et al.

Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.

Am J Obstet Gynecol. 190: 737-744Dombrowski M.P. Brown C.L. Berry S.M.

Preliminary experience with triamcinolone acetonide during pregnancy.

J Maternal-Fetal Med. 5: 310-313Källén B. Rydhstroem H. Åberg A.

Congenital malformations after the use of inhaled budesonide in early pregnancy.

Obstet Gynecol. 93: 392-395Källén B. Olausson P.O.

Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications.

Eur J Clin Pharmacol. 63: 363-373Källén B.A. Olausson P.O.

Maternal drug use in early pregnancy and infant cardiovascular defect.

Reprod Toxicol. 17: 255-261Namazy J. Schatz M. Long L. et al.

Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth.

J Allergy Clin Immunol. 113: 427-432Blais L. Beauchesne M.-F. Rey É. et al.

Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.

Thorax. 62: 320-328

Use of drugs during pregnancy—unique Swedish registration method that can be improved.

Inf Swedish Med Prod agency. 1: 8-11Olesen C. Thrane N. Nielsen G.L. et al.

A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes.

Respiration. 68: 256-261Blais L. Beauchesne M.-F. Lemière C. et al.

High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations.

J Allergy Clin Immunol. 124: 1229-1234. e1224Norjavaara E. de Verdier M.G.

Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide.

J Allergy Clin Immunol. 111: 736-742

A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.

Curr Med Res Opin. 21: 1075-1084Suissa S. Ernst P. Boivin J.-F. et al.

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

Am J Respir Crit Care Med. 149: 604-610Garne E. Vinkel Hansen A. Morris J. et al.

Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy–a cohort linkage study.

BJOG: An Int J Obstet Gynaecol. 123: 1609-1618Eltonsy S. Kettani F.-Z. Blais L.

Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review.

Respir Med. 108: 9-33Cossette B. Beauchesne M.-F. Forget A. et al.

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.

Ann Allergy Asthma Immunol. 112: 459-464Satia I. Cusack R. O’Byrne P.

Paradigm shift in the management of mild asthma: Focus toward a patient centered approach.

Can J Respir Crit Care Sleep Med. 4: 55-60Cusack R.P. Satia I. O’Byrne P.M.

Asthma maintenance and reliever therapy: Should this be the standard of care?.

Ann Allergy Asthma Immunol. 125: 150-155Eltonsy S. Forget A. Beauchesne M.-F. et al.

Risk of congenital malformations for asthmatic pregnant women using a long-acting β2-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.

J Allergy Clin Immunol. 135: 123-130. e122Park-Wyllie L. Mazzotta P. Pastuszak A. et al.

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.

Teratology. 62: 385-392Skuladottir H. Wilcox A.J. Ma C. et al.

Corticosteroid use and risk of orofacial clefts.

Birth Defects Res Part A: Clin Mol Teratology. 100: 499-506Howley M.M. Papadopoulos E.A. Van Bennekom C.M. et al.

Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997–2011.

J Allergy Clin Immunol In Pract. 8: 3490-3499.e9Blais L. Kettani F.-Z. Forget A. et al.

Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.

Thorax. 70: 647-652

Safety of antileukotriene agents in asthma management.

Ann Allergy Asthma Immunol. 86: 18-23Cavero-Carbonell C. Vinkel-Hansen A. Rabanque-Hernández M.J. et al.

Fetal exposure to montelukast and congenital anomalies: a population based study in Denmark.

Birth defects Res. 109: 452-459Sarkar M. Koren G. Kalra S. et al.

Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.

Eur J Clin Pharmacol. 65: 1259-1264Kim L.H. Saleh C. Whalen-Browne A. et al.

Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.

JAMA. 325: 2466-2479

NAEPP expert panel report: managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update.

J Allergy Clin Immunol. 115: 34-46Weinberger M. Hendeles L.

Theophylline in asthma.

N Engl J Med. 334: 1380-1388

Theophylline.

Am J Of Respir And Crit Care Med. 188: 901-906

Genentech. Xolair (omalizumab): full prescribing information.

() ()Namazy J.A. Blais L. Andrews E.B. et al.

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.

J Allergy Clin Immunol. 145 (): 528-536Yancey S.W. Keene O.N. Albers F.C. et al.

Biomarkers for severe eosinophilic asthma.

J Allergy Clin Immunol. 140: 1509-1518

Glaxosmithkline. Nucala (mepolizumab): summary of product characteristics. 2021.

Reslizumab (Cinqair): an Interleukin-5 antagonist for severe asthma of the eosinophilic phenotype.

P T. 42: 564 () ()

Regeneron. Dupixent (dupilumab): prescribing information.

() ()Kage P. Simon J. Treudler R.

A case of atopic eczema treated safely with dupilumab during pregnancy and lactation.

J Eur Acad Dermatol Venereol. 34: e256-e257Mian M. Dunlap R. Simpson E.

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report.

JAAD Case Rep. 6: 1051Lobo Y. Lee R.C. Spelman L.

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature.

Case Rep Dermatol. 13: 248-256

European Medicines Agency (EMA): assessment report; dupilumab. 2017.

Knudsen U.B. Hansen V. Juul S. et al.

Prognosis of a new pregnancy following previous spontaneous abortions.

Eur J Obstet Gynecol Reprod Biol. 39: 31-36

Subfertility and risk of spontaneous abortion.

Am J Public Health. 90: 1452

European Medicines Agency (EMA): Summary of product characteristics. 2020.

Cusack R.P. Whetstone C.E. Xie Y. et al.

Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment.

Cells. 10: 817Kabata H. Moro K. Fukunaga K. et al.

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

Nat Commun. 4: 1-10

Astrazeneca. Tezspire™(tezepelumab) prescribing information: 2021.

Menzies-Gow A. Corren J. Bourdin A. et al.

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

N Engl J Med. 384: 1800-1809Lupattelli A. Spigset O. Twigg M.J. et al.

Medication use in pregnancy: a cross-sectional, multinational web-based study.

BMJ open. 4: e004365

留言 (0)

沒有登入
gif